ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

August 2, 1985

Soviet Exchanges Rise And Fall With Politics

August 23, 1991

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

In Brief: Hawaii Center Searching For New Director: Rosenberg Denies Report He’s Going To Tampa

June 7, 1985

A History of NCCN

January 13, 2012

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002